Flexible Electrodes

Researchers at the Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences and collaborating institutions have developed a neural electrode interface that, they report, significantly extended electrode operational lifetime and improved signal fidelity over six months of in vivo implantation. The material, a benzyloxycarbonyl-substituted poly(ornithine-alt-glycine) coating abbreviated OGCbz, resists biofouling and immunogenic rejection without degrading electrical performance, targeting what the authors call the critical obstacle to electrodes that combine long-term recording with tunable biofunctional control: an immune-mediated foreign body response in which glial scar encapsulates implants like cement. Substituting the Cbz group with other functional moieties preserves those antifouling and biocompatibility properties while adding new ones, and as a proof of concept the peptide sequence IKVAV and the antibody cetuximab gave the interface neuron affinity and tumor cell proliferation inhibition respectively; the six-month result came from the IKVAV-functionalized version.

Implantable brain-computer interfaces are shifting from rigid silicon architectures to soft, structurally adaptive systems built for seamless, long-term integration with neural tissue, according to a review of flexible electrode materials and structural design published in SmartMat on August 31, 2026. Breakthroughs in materials science and micro/nanofabrication have given this generation of devices mechanical compliance, robust interfacial adhesion and high-fidelity signal acquisition that earlier designs could not reach, the review says. Long-term stability at the electrode-tissue interface remains one of the core bottlenecks for invasive BCI.

A team from the University of Utah, Kangwon National University and the University of Georgia describes a silicon-free route to neural microelectrode arrays: soft polymeric 3D microneedles are printed by two-photon polymerization, then turned into electrodes by injecting liquid gallium into the hollow channels. A newly defined retention number predicts whether the gallium stays put under physiological conditions. Coating the surface with gold nanoparticles and PEDOT doped with tetrafluoroborate cut impedance by roughly 3 orders of magnitude, and in vivo recordings in an invertebrate model captured neural spikes with no gallium leakage. The study was published in ACS Sensors on August 31, 2026.

Researchers at the Second Affiliated Hospital of Xi'an Jiaotong University in northwestern China and the Key Laboratory of Biomedical Information Engineering of the Ministry of Education have built an in vitro screening platform combining electrospun PLCL with inkjet-printed reduced graphene oxide (rGO) and growth-factor micropatterns. Because it varies conductive, biochemical and topographical cues together, the platform can evaluate printing parameters and electric-field strength in a single system. Under 150 mV/cm direct-current stimulation, PC-12 cells showed more neurite-like outgrowth and better alignment than with no stimulation or at 300 mV/cm.

Researchers at the Institute of Biological Information Processing at Forschungszentrum Jülich posted a preprint to bioRxiv on August 4, 2026, proposing hierarchical, dendrite-inspired organic bioelectronic interfaces built to integrate with neurons. Brain-computer interfaces depend on intimate electrical communication between living neurons and artificial materials, the authors write, yet conventional electrode architectures remain structurally unlike neural tissue, limiting stable cell-electrode coupling and long-term recording. The work is a preprint and has not been peer reviewed.

The FDA has cleared Precision Neuroscience's Layer 7 Cortical Interface to stay implanted for up to 30 days, up from a previous 510(k) limit of 30 minutes of intraoperative use. The longer window opens the door to extended clinical studies and marks an intermediate step toward a permanent implant.

Surgeons in eastern China have implanted a brain-computer interface in a man who has been unable to move his limbs for more than two years. Eight ultraflexible electrodes sit 4 mm into his cortex, wired to a chip mounted on the skull. It is the first invasive BCI operation performed in Shandong province, and the patient now begins up to six months of training to control devices by thought.

Researchers at the University of Washington have built mechanically compliant, precision-porous brain implants and tested them in rat brains. At 4 weeks, the porous scaffolds drew less astrocyte encapsulation than solid hydrogel rods, softer hydrogels reduced pro-inflammatory macrophage polarization, and new blood vessels, neuronal markers and neurogenesis appeared inside the pores. The authors present the design as a route to limiting glial scarring and improving regeneration in implant-based central nervous system therapies.

Researchers transferred dexamethasone-loaded titania nanotube arrays (TNA) onto a mechanically adaptive polymer nanocomposite (NC) substrate and, in a mouse model, compared four implants — silicon, NC, TNA-NC Empty and TNA-NC DEX (10 mice per group) — for neuroinflammation around intracortical microelectrodes at 2 and 4 weeks. At 2 weeks the gene-expression profiles were broadly similar, reflecting an early acute injury response; by 4 weeks the patterns diverged, with NC-based implants showing fewer differentially expressed neuroinflammatory genes than rigid silicon, led by TNA-NC Empty, while the dexamethasone group showed no additional benefit, suggesting drug delivery still needs optimization. The authors conclude that adding a TNA layer to flexible materials promotes resolution of the neuroinflammatory response at 4 weeks.

A Nature Communications study tested ultra-Flexible Implantable Neural Electrode arrays during awake surgery in 16 patients. Valid single-unit recordings were obtained in 11 patients, yielding 719 isolated neurons and as many as 135 simultaneously, while five early cases failed because of operating-room noise or damaged insertion needles. The work was intraoperative and does not establish long-term implant performance.

NeuroXess broke ground on a roughly 14,300-square-meter BCI manufacturing project in Jiangxi province in eastern China. The company said the facility would produce flexible implantable electrodes, neural recording equipment, surgical robots and fully implanted wireless BCI systems, with a target of stable supply at the 10,000-unit scale. NeuroXess expects the factory to begin operating in the second half of 2026, but the capacity and timeline remain company projections.

NeuroXess and Huashan Hospital reported a single-patient test of a 256-channel flexible implantable BCI. In postoperative training, decoding accuracy reached 71% across 142 commonly used Mandarin syllables, with per-character latency below 100 milliseconds. The participant had a language-area tumor and epilepsy, so the company-reported result does not establish performance in people who have lost speech.